News
Ozempic maker Novo Nordisk confirmed Tuesday its popular weight loss drug Wegovy had been approved for sale in China, a key victory for the Danish firm that opens the door to an enormous market ...
Daily Voice on MSN12h
Plainsboro-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug SalesNovo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...
Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make ...
of Danish drugmaker Novo Nordisk rose Tuesday after the company announced that its popular weight-loss drug Wegovy has been approved to start being sold in China. Ozempic, another drug with the ...
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk NOVO.B1.91%increase; green up pointing triangle to begin selling it in the world’s second ...
The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...
The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...
SHANGHAI, June 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results